Adenovirus-Associated Virus Vector???Mediated Gene Transfer in Hemophilia B, New England Journal of Medicine, vol.365, issue.25, pp.2357-2365, 2011. ,
DOI : 10.1056/NEJMoa1108046
URL : http://europepmc.org/articles/pmc3265081?pdf=render
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial, The Lancet, vol.374, issue.9701, pp.1597-1605, 2009. ,
DOI : 10.1016/S0140-6736(09)61836-5
Lessons Learned from the Clinical Development and Market Authorization of Glybera, Human Gene Therapy Clinical Development, vol.24, issue.2, pp.55-64, 2013. ,
DOI : 10.1089/humc.2013.087
URL : http://europepmc.org/articles/pmc3992977?pdf=render
Characterization of a Recombinant Adeno-Associated Virus Type 2 Reference Standard Material, Human Gene Therapy, vol.21, issue.10, pp.1273-1285, 2010. ,
DOI : 10.1089/hum.2009.223
URL : http://europepmc.org/articles/pmc2957240?pdf=render
Manufacturing and Characterization of a Recombinant Adeno-Associated Virus Type 8 Reference Standard Material, Human Gene Therapy, vol.25, issue.11, pp.977-987, 2014. ,
DOI : 10.1089/hum.2014.057
URL : http://europepmc.org/articles/pmc4236062?pdf=render
International Efforts for Recombinant Adeno-associated Viral Vector Reference Standards, Molecular Therapy, vol.16, issue.7, pp.1185-1188, 2008. ,
DOI : 10.1038/mt.2008.125
URL : https://doi.org/10.1038/mt.2008.125
Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR, Journal of Virological Methods, vol.106, issue.1, pp.81-88, 2002. ,
DOI : 10.1016/S0166-0934(02)00138-6
FDA Statement Regarding the Use of Adeno-Associated Virus Reference Standard Materials, Human Gene Therapy Methods, vol.26, issue.1, p.3, 2015. ,
DOI : 10.1089/hgtb.2015.1501
Systematic Comparison and Validation of Quantitative Real-Time PCR Methods for the Quantitation of Adeno-Associated Viral Products, Human Gene Therapy Methods, vol.26, issue.3, pp.82-92, 2015. ,
DOI : 10.1089/hgtb.2015.013
Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences, Human Gene Therapy Methods, vol.23, issue.1, pp.18-28, 2012. ,
DOI : 10.1089/hgtb.2011.034
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response, Nature Medicine, vol.24, issue.3, pp.342-347, 2006. ,
DOI : 10.1002/hep.1840200104
Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods, Human Gene Therapy Methods, vol.23, issue.1, pp.1-7, 2012. ,
DOI : 10.1089/hgtb.2011.104
A reliable and feasible qPCR strategy for titrating AAV vectors, Medical Science Monitor Basic Research, vol.19, pp.187-193, 2013. ,
DOI : 10.12659/MSMBR.883968
URL : http://europepmc.org/articles/pmc3706409?pdf=render
Helper-free stocks of recombinant adenoassociated viruses: normal integration does not require viral gene expression, J Virol, vol.63, pp.3822-3828, 1989. ,
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency, Gene Therapy, vol.17, issue.4, pp.503-510, 2010. ,
DOI : 10.1182/blood-2007-03-080093
URL : http://www.nature.com/gt/journal/v17/n4/pdf/gt2009157a.pdf
Serious Overestimation in Quantitative PCR by Circular (Supercoiled) Plasmid Standard: Microalgal pcna as the Model Gene, PLoS ONE, vol.5, issue.3, p.9545, 2010. ,
DOI : 10.1371/journal.pone.0009545.t003
URL : https://doi.org/10.1371/journal.pone.0009545
Absolute Determination of Single-Stranded and Self-Complementary Adeno-Associated Viral Vector Genome Titers by Droplet Digital PCR, Human Gene Therapy Methods, vol.25, issue.2, pp.115-125, 2014. ,
DOI : 10.1089/hgtb.2013.131
URL : http://europepmc.org/articles/pmc3991984?pdf=render
Evaluation of Digital PCR for Absolute DNA Quantification, Analytical Chemistry, vol.83, issue.17, pp.6474-6484, 2011. ,
DOI : 10.1021/ac103230c
Development of a Rapid, Robust, and Universal PicoGreen-Based Method to Titer Adeno-Associated Vectors, Human Gene Therapy Methods, vol.26, issue.1, pp.35-42, 2015. ,
DOI : 10.1089/hgtb.2014.120
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments, Clinical Chemistry, vol.55, issue.4, pp.611-622, 2009. ,
DOI : 10.1373/clinchem.2008.112797
URL : http://clinchem.aaccjnls.org/content/clinchem/55/4/611.full.pdf
Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle doselimiting side-effects, Mol Ther Methods Clin Dev, vol.1, p.20139, 2014. ,
DOI : 10.1038/mtm.2013.9
URL : https://doi.org/10.1038/mtm.2013.9
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys, Science Translational Medicine, vol.109, issue.4, pp.194-92, 2013. ,
DOI : 10.1182/blood-2006-03-010181
URL : http://europepmc.org/articles/pmc4095828?pdf=render
CD8+ T-cell responses to adeno-associated virus capsid in humans, Nature Medicine, vol.12, issue.4, pp.419-422, 2007. ,
DOI : 10.1038/nm1549
Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector., Proceedings of the National Academy of Sciences, vol.89, issue.15, pp.7257-7261, 1992. ,
DOI : 10.1073/pnas.89.15.7257
URL : http://www.pnas.org/content/89/15/7257.full.pdf
A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells, Molecular Therapy, vol.17, issue.11, pp.1888-1896, 2009. ,
DOI : 10.1038/mt.2009.128
URL : https://doi.org/10.1038/mt.2009.128
Insect Cells as a Factory to Produce Adeno-Associated Virus Type 2 Vectors, Human Gene Therapy, vol.13, issue.16, pp.1935-1943, 2002. ,
DOI : 10.1089/10430340260355347